Virbac SA (VRBCF)
436.32
0.00 (0.00%)
USD |
OTCM |
Dec 12, 16:00
Virbac Enterprise Value: 3.618B for Dec. 12, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 448.80M |
| Cellectis SA | 396.52M |
| Innate Pharma SA | -- |
| Inventiva SA | 599.14M |
| Nanobiotix SA | -- |
Enterprise Value Related Metrics
| Earnings Yield | 3.96% |
| Operating Earnings Yield | 5.91% |
| Normalized Earnings Yield | 3.984 |